Literature DB >> 11064618

Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord.

C S Wong1, M M Hsu, Y Y Chou, P L Tao, C S Tung.   

Abstract

N-Methyl-D-aspartate (NMDA) receptor antagonists and nitric oxide synthase (NOS) inhibitors inhibit morphine tolerance. In the present study, a lumbar subarachnoid polyethylene (PE10) catheter was implanted for drug administration to study alterations in NMDA receptor activity and NOS protein expression in a morphine-tolerant rat spinal model. Antinociceptive tolerance was induced by intrathecal (i.t.) morphine infusion (10 micrograms h-1) for 5 days. Co-administered (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801) (10 micrograms h-1 i.t.) with morphine was used to inhibit the development of morphine tolerance. Lumbar spinal cord segments were removed and prepared for [3H]MK-801 binding assays and NOS western blotting. The binding affinity of [3H]MK-801 was higher in spinal cords of morphine-tolerant rats (mean (SEM) KD = 0.41 (0.09) nM) than in control rats (1.50 (0.13) nM). There was no difference in Bmax. Western blot analysis showed that constitutive expression of neuronal NOS (nNOS) protein in the morphine-tolerant group was twice that in the control group. This up-regulation was partially prevented by MK-801. The results suggest that morphine tolerance affects NMDA receptor binding activity and increases nNOS expression in the rat spinal cord.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064618     DOI: 10.1093/bja/85.4.587

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  8 in total

Review 1.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

2.  Neuron-astrocyte signaling network in spinal cord dorsal horn mediates painful neuropathy of type 2 diabetes.

Authors:  Jacqueline R Dauch; Brandon M Yanik; Wilson Hsieh; Sang Su Oh; Hsinlin T Cheng
Journal:  Glia       Date:  2012-05-09       Impact factor: 7.452

Review 3.  Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  Peptides       Date:  2019-03-16       Impact factor: 3.750

4.  Fentanyl-induced hyperalgesia and analgesic tolerance in male rats: common underlying mechanisms and prevention by a polyamine deficient diet.

Authors:  Emilie Laboureyras; Meric Ben Boujema; Annie Mauborgne; John Simmers; Michel Pohl; Guy Simonnet
Journal:  Neuropsychopharmacology       Date:  2021-10-07       Impact factor: 7.853

5.  Blockade of NMDA receptors prevents analgesic tolerance to repeated transcutaneous electrical nerve stimulation (TENS) in rats.

Authors:  Priyanka M Hingne; Kathleen A Sluka
Journal:  J Pain       Date:  2007-12-03       Impact factor: 5.820

Review 6.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

Review 7.  Opioids Resistance in Chronic Pain Management.

Authors:  Luigi A Morrone; Damiana Scuteri; Laura Rombolà; Hirokazu Mizoguchi; Giacinto Bagetta
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

8.  Cyclosporin A attenuating morphine tolerance through inhibiting NO/ERK signaling pathway in human glioblastoma cell line: the involvement of calcineurin.

Authors:  Asma Rashki; Faiza Mumtaz; Farahnaz Jazayeri; Amir Shadboorestan; Jamileh Esmaeili; Shahram Ejtemaei Mehr; Mohammad Hossein Ghahremani; Ahmad Reza Dehpour
Journal:  EXCLI J       Date:  2018-11-12       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.